Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Helicobacter pylori is a major human pathogen associated with significant morbidity. The treatment oriented by the antibiogram or PCR (Polymerase Chain Reaction) should be privileged in children. However, the optimal treatment for the eradication of pediatric H. pylori infection is still not established.
No French consensus conference on the management of H. pylori infection in children taking into account the epidemiological data available for this infection has been published. The description of diagnostic and therapeutic management procedures has not yet been specifically described according to the country of birth of children. The main objective is to collect data enabling the establishment of a French observatory of Helicobacter pylori in children in order to provide a national database.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| children with H. pylori infection |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Collection of data | Other | The following data will be collected by the physician : sociodemographic profile (age, sex, country of birth of child and parents); clinical manifestations; endoscopic aspects (esophagus, duodenum, stomach); different methods of diagnosis of infection; different primary and secondary bacterial resistance profiles ; different first and second line therapeutic combinations; different first and second line bacterial eradication rates ; different signs of side effects and tolerance of first and second line treatments; different methods of bacterial eradication control. |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnosis of H. pylori infection | Child with confirmed H. pylori infection by direct diagnostic methods (Histology, Bacterial culture, PCR) on perendoscopic gastric biopsies | at inclusion |
| Age | at inclusion | |
| Sex | at inclusion | |
| Country of birth | at inclusion | |
| Clinical symptoms | at inclusion, 3 and 6 months | |
| Microbiological diagnosis | at inclusion, 3 and 6 months | |
| Endoscopic diagnosis | at inclusion, 3 and 6 months | |
| Rates of bacterial resistance profiles | at inclusion, at 3 and 6 months | |
| antibiotic therapy | at inclusion, 3 and 6 months | |
| Bacterial eradication rates | 3 and 6 months | |
| Side effects and tolerance of first and second line treatments | 3 and 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Children with confirmed diagnosis of H. pylori infection
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicolas Kalach, PR | Lille Catholic University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lille Catholic University | Lille | 59000 | France |
Not provided
Not provided
Not provided
Not provided
gastric biopsy for histological analysis, culture of bacteria and Polymerase Chain Reaction (PCR)
|